![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: TAOK2 (CAeditome ID:9344) |
Gene summary for TAOK2 |
![]() |
Gene information | Gene symbol | TAOK2 | Gene ID | 9344 |
Gene name | TAO kinase 2 | |
Synonyms | MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2 | |
Cytomap | 16p11.2 | |
Type of gene | protein-coding | |
Description | serine/threonine-protein kinase TAO2PSK-1hKFC-Ckinase from chicken homolog Cprostate derived STE20-like kinase PSKprostate-derived STE20-like kinase 1prostate-derived sterile 20-like kinase 1thousand and one amino acid protein kinase 2 | |
Modification date | 20210518 | |
UniProtAcc | Q9UL54 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
TAOK2 | GO:0004674 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0004674 | Serine/threonine-protein kinase TAO2 | 11279118 |
TAOK2 | GO:0000186 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0006974 | Serine/threonine-protein kinase TAO2 | 17396146 |
TAOK2 | GO:0008360 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0030036 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0046330 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0048041 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0051403 | Serine/threonine-protein kinase TAO2 | 11279118 |
TAOK2 | GO:0005654 | Serine/threonine-protein kinase TAO2 | 0000052 |
TAOK2 | GO:0005730 | Serine/threonine-protein kinase TAO2 | 0000052 |
TAOK2 | GO:0005829 | Serine/threonine-protein kinase TAO2 | 0000052 |
TAOK2 | GO:0031410 | Serine/threonine-protein kinase TAO2 | 10660600 |
TAOK2 | GO:0043235 | Serine/threonine-protein kinase TAO2 | 23382219 |
Top |
RNA A-to-I events for TAOK2 |
![]() |
![]() |
![]() |
![]() |
CAediting_1109833(29991515, +), |
Top |
RNA editing positional annotations for TAOK2 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_1109833 | chr16_29991515_+ | nonsynonymous SNV | ENST00000279394.6 | c.A3097G | p.S1033G | D | D | N |
![]() |
CAeditome ID | Position | Variant type |
CAediting_1109833 | chr16_29991515_+ | exonic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
Top |
RNA A-to-I editing events in the alternative splicing sites for TAOK2 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for TAOK2 |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for TAOK2 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for TAOK2 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_604450 | chr7_133034877_- | ENSG00000149930.16 | ENST00000543033 | hsa-miR-3654 | 29988153 | 29988160 | 8mer-1a | 29988138 | 29988160 | 159 | -29.47 |
CAediting_1054808 | chr15_66496985_- | ENSG00000149930.16 | ENST00000279394 | hsa-miR-4512 | 29991644 | 29991650 | 7mer-m8 | 29991629 | 29991651 | 151 | -26.42 |
CAediting_1368054 | chr19_46709310_- | ENSG00000149930.16 | ENST00000279394 | hsa-miR-320e | 29991679 | 29991685 | 7mer-m8 | 29991668 | 29991686 | 142 | -14.1 |
CAediting_396018 | chr5_1062918_- | ENSG00000149930.16 | ENST00000279394 | hsa-miR-4635 | 29991757 | 29991763 | 7mer-m8 | 29991744 | 29991764 | 141 | -19.37 |
CAediting_604450 | chr7_133034877_- | ENSG00000149930.16 | ENST00000416441 | hsa-miR-3654 | 29988153 | 29988160 | 8mer-1a | 29988138 | 29988160 | 159 | -29.47 |
CAediting_468389 | chr6_31355314_- | ENSG00000149930.16 | ENST00000543033 | hsa-miR-6891-5p | 29988137 | 29988144 | 8mer-1a | 29988126 | 29988144 | 140 | -19.34 |
CAediting_468389 | chr6_31355314_- | ENSG00000149930.16 | ENST00000279394 | hsa-miR-6891-5p | 29991694 | 29991701 | 8mer-1a | 29991685 | 29991701 | 146 | -31.2 |
CAediting_468389 | chr6_31355314_- | ENSG00000149930.16 | ENST00000416441 | hsa-miR-6891-5p | 29988137 | 29988144 | 8mer-1a | 29988126 | 29988144 | 140 | -19.34 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_1368054 | chr19_46709310_- | ENSG00000149930.16 | ENST00000279394 | hsa-miR-320e | 29991739 | 29991745 | 7mer-m8 | 29991728 | 29991746 | 141 | -13.19 |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for TAOK2 |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for TAOK2 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for TAOK2 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for TAOK2 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for TAOK2 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
TAOK2 | Q9UL54 | DB12010 | Fostamatinib | Serine/threonine-protein kinase TAO2 | SmallMoleculeDrug | approved|investigational |
Top |
RelatedDiseases for TAOK2 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |